Mike Tyson Autographed Boxing Gloves Event Raised More Than $250,000 for Pediatric Cancer Research and Treatment

Mike Tyson (left), Dave Cantin, Executive Chairman and CEO (center), and Valentina Nejfelt celebrate the auctioning of autographed boxing gloves at Dave Cantin Group’s event on behalf of DCG Giving. Photo credit: Matt Carroll, Colossus Media Group

DCG Giving, a Dave Cantin Group Partnership, Delivers a Knockout Punch to Pediatric Cancer Through its Fundraising Auction of Mike Tyson Autographed Boxing Gloves

February 23, 2023 NEW YORK--(BUSINESS WIRE)--The Dave Cantin Group (DCG), one of the largest automotive industry financial advisory services companies specializing in buy/sell transactions, announced today that its nonprofit partnership DCG Giving raised more than $250,000 at its first fundraising event of 2023. The dinner, headlined by legendary heavyweight champion Mike Tyson, took place at DCG’s exclusive, invitation-only VIP afterparty at the National Automobile Dealers Association (NADA) annual show in Dallas, at Del Frisco’s Double Eagle Steakhouse. The event auctioned off autographed boxing gloves by Mike Tyson.

Proceeds from the DCG Giving fundraising event will directly support its partner, the Children's Oncology Group (COG) – the world's largest organization devoted exclusively to childhood and adolescent cancer research and treatment.

“Only about 4% of all federal funding for cancer research is spent on projects involving children's cancers-that is simply not enough,” says Dave Cantin, Executive Chairman and CEO, DCG. “In 2022, DCG Giving donated more than half a million dollars to child and adolescent cancer research and treatment efforts, and we are excited to continue our efforts with more donations and events in 2023. ”

Also in attendance was Dr. Stephen X. Skapek, Chief, Division of Hematology/Oncology in the Department of Pediatrics at UT Southwestern Medical Center and a member of its Harold C. Simmons Comprehensive Cancer Center, a COG member. The Division is nationally distinguished for its design and conduct of NIH-funded multicenter clinical trials involving childhood cancer and blood disease.

“Childhood cancer is not just one disease. There are actually dozens of subtypes,” Dr. Skapek says. “Even though more than 95% of children with certain subtypes will be cured, chance of survival is much less in many other subtypes. We work tirelessly to change those percentages.”

He added, “From identifying proteins that can be ‘targeted’ as novel therapies in childhood cancer to understanding how certain cancer-causing mutations influence the metabolism in childhood brain tumors and certain types of sarcomas, our research remains in the forefront of diagnosing and caring for infants, children, and adolescents with cancer and blood disorders.”

DCG Giving’s fundraising proceeds support state-of-the-art research and treatment for children with cancer in communities nationwide, hallmarking DCG Giving’s mission to the 3 C’s: Children, Cancer, and Community. Visit DCG Giving to learn more and donate.

About Dave Cantin Group
The Dave Cantin Group (DCG) headquartered in New York City, services the automotive industry nationwide. As a holding company, DCG is comprised of DCG Acquisitions, the Mergers & Acquisitions arm of the organization, DCG Acquisitions in one of the largest automotive M&A firms in the automotive industry, specializing in automotive buy/sell transactions; DCG Capital provides capital-focused services for automotive dealers and industry service providers; DCG Media curates and syndicates automotive-specific media; and DCG Giving, the organizations nonprofit committed to funding lifesaving child and adolescent cancer research and treatment. To learn more, visit www.davecantingroup.com